Page last updated: 2024-10-25

cilostazol and Delayed Effects, Prenatal Exposure

cilostazol has been researched along with Delayed Effects, Prenatal Exposure in 1 studies

Research Excerpts

ExcerptRelevanceReference
"The cilostazol regimen, attenuated prenatal VPA exposure associated hyperlocomotion, social interaction deficits, repetitive behavior, and anxiety."8.02Cilostazol attenuated prenatal valproic acid-induced behavioural and biochemical deficits in a rat model of autism spectrum disorder. ( Kulkarni, GT; Luhach, K; Sharma, B; Singh, VP, 2021)
"The cilostazol regimen, attenuated prenatal VPA exposure associated hyperlocomotion, social interaction deficits, repetitive behavior, and anxiety."4.02Cilostazol attenuated prenatal valproic acid-induced behavioural and biochemical deficits in a rat model of autism spectrum disorder. ( Kulkarni, GT; Luhach, K; Sharma, B; Singh, VP, 2021)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Luhach, K1
Kulkarni, GT1
Singh, VP1
Sharma, B1

Other Studies

1 other study available for cilostazol and Delayed Effects, Prenatal Exposure

ArticleYear
Cilostazol attenuated prenatal valproic acid-induced behavioural and biochemical deficits in a rat model of autism spectrum disorder.
    The Journal of pharmacy and pharmacology, 2021, Oct-07, Volume: 73, Issue:11

    Topics: Animals; Anticonvulsants; Anxiety; Autism Spectrum Disorder; Behavior, Animal; Biomarkers; Brain; Ci

2021